Please use this identifier to cite or link to this item: https://saber.ucv.ve/jspui/handle/10872/17832
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMontes de Oca, Maria-
dc.contributor.authorAguirre, Carlos-
dc.contributor.authorLopez Varela, Maria Victorina-
dc.contributor.authorLaucho Contreras, Maria Eugenia-
dc.contributor.authorCasas, Alejandro-
dc.contributor.authorSurmont, Filip-
dc.date.accessioned2018-02-22T15:19:23Z-
dc.date.available2018-02-22T15:19:23Z-
dc.date.issued2016-12-07-
dc.identifier.citationMontes de Oca et al, Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study.Int J Chron Obstruct Pulmon Dis. 2016 Dec 7;11:3059-306en_US
dc.identifier.issn1178-2005-
dc.identifier.urihttp://hdl.handle.net/10872/17832-
dc.description.abstractBackground: COPD, asthma, and asthma–COPD overlap increase health care resource consumption, predominantly because of hospitalization for exacerbations and also increased visits to general practitioners (GPs) or specialists. Little information is available regarding this in the primary care setting. Objectives: To describe the prevalence and number of GP and specialist visits for any cause or due to exacerbations in patients with COPD, asthma, and asthma–COPD overlap. Methods: COPD was defined as post-bronchodilator forced expiratory volume in 1 second/ forced vital capacity (FEV 1 /FVC) ratio , 0.70; asthma was defined as prior medical diagnosis, wheezing in the last 12 months, or wheezing plus reversibility (post-bronchodilator FEV 1 or FVC increase $ 200 mL and $ 12%); asthma–COPD overlap was defined as post-bronchodilator FEV 1 /FVC , 0.70 plus prior asthma diagnosis. Health care utilization was evaluated as GP and/or specialist visits in the previous year. Results: Among the 1,743 individuals who completed the questionnaire, 1,540 performed acceptable spirometry. COPD patients had a higher prevalence of any medical visits to any physician versus those without COPD (37.2% vs 21.8%, respectively) and exacerbations doubled the number of visits. The prevalence of any medical visits to any physician was also higher in asthma patients versus those without asthma (wheezing: 47.2% vs 22.7%; medical diagnosis: 54.6% vs 21.6%; wheezing plus reversibility: 46.2% vs 23.8%, respectively). Asthma patients with exacerbations had twice the number of visits versus those without an exacerbation. The number of visits was higher (2.8 times) in asthma–COPD overlap, asthma (1.9 times), or COPD (1.4 times) patients versus those without these respiratory diseases; the number of visits due to exacerbation was also higher (4.9 times) in asthma–COPD overlap, asthma (3.5 times), and COPD (3.8 times) patients. Conclusion: COPD, asthma, and asthma–COPD overlap increase the prevalence of medical visits and, therefore, health care resource utilization. Attempts to reduce health care resource use in these patients require interventions aimed at preventing exacerbations.en_US
dc.description.sponsorshipAstraZeneca Latin America.en_US
dc.language.isoenen_US
dc.publisherInternational Journal of COPDen_US
dc.subjectCOPDen_US
dc.subjectasthmaen_US
dc.subjectEPOCen_US
dc.subjectexacerbationsen_US
dc.subjecthealth care resource utilizationen_US
dc.subjectprimary careen_US
dc.subjectPUMA studyen_US
dc.subjectAtencion Primariaen_US
dc.titleexacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA studyen_US
dc.typeArticleen_US
Appears in Collections:Artículos Publicados

Files in This Item:
File Description SizeFormat 
copd-11-3059.pdf560.4 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.